Abstract
Pigment epithelium-derived factor (PEDF) is an oncogene found in various types of cancers. However, how PEDF affects the development of human esophageal squamous cell carcinoma (ESCC) is unknown. This study investigates the role of PEDF in ESCC cell proliferation, migration, and cell cycle both in vitro and in vivo. The PEDF expression was examined in patient tumor samples and ESCC cell lines. Short hairpin RNA technology was used to inhibit the PEDF expression in ESCC EC9706 and KYSE150 cells. In vitro cell proliferation and migration assays were performed. The effects of PEDF on tumor growth and progression were examined in vivo in murine subcutaneous xenograft tumor models. It was found that PEDF was overexpressed in esophageal cancer cells and patient tumor tissues compared to normal control samples. PEDF enhanced cell cycle progression and inhibited cell apoptosis. Knock down of PEDF inhibited esophageal cell proliferation and migration in vitro. Moreover, Inhibition of PEDF significantly reduced tumor growth and tumor size in vivo. These results indicate that PEDF induce tumorigenesis in ESCC and can be a potential therapeutic target for cancer treatment.
Highlights
Esophageal carcinoma is a common gastrointestinal cancer that has two major subtypes: adenocarcinoma and squamous cell carcinoma [1]
Pigment epithelium-derived factor (PEDF) Is Overexpressed in Esophageal Squamous Cell Carcinoma
These results indicated that PEDF is associated with the development of esophageal squamous cell carcinoma (ESCC)
Summary
Esophageal carcinoma is a common gastrointestinal cancer that has two major subtypes: adenocarcinoma and squamous cell carcinoma [1]. PEDF Promotes Esophageal Cancer Growth roles in many physiological and pathophysiological processes, including neuroprotection, fibrosis and inflammation [11]. The level of PEDF is higher than that of normal tissues in some other cancers. PEDF was found in hepatocellular carcinoma cells where PEDF levels were higher in HCC cases than in normal paracancerous tissues. We found that PEDF is overexpressed in tissues and cells of esophageal carcinoma. We observed that PEDF promotes esophageal cancer cell growth both in vivo and in vitro. This study will provide a rational for using PEDF as a prognostic biomarker and a potential therapeutic target for esophageal carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.